| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Begor Mark W | CEO, Director | 1550 PEACHTREE STREET, N.W., ATLANTA | /s/Lisa Stockard as Attorney-in-Fact | 29 Oct 2025 | 0001335111 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EFX | Common Stock | Options Exercise | $5,352,471 | +27,959 | +20% | $191.44 | 170,940 | 27 Oct 2025 | Direct | F1, F2 |
| transaction | EFX | Common Stock | Gift | $0 | -47 | -0.03% | $0.000000 | 170,893 | 27 Oct 2025 | Direct | F2 |
| transaction | EFX | Common Stock | Sale | $40,694 | -174 | -0.1% | $233.88 | 170,719 | 27 Oct 2025 | Direct | F1, F2, F3 |
| transaction | EFX | Common Stock | Sale | $47,985 | -204 | -0.12% | $235.22 | 170,515 | 27 Oct 2025 | Direct | F1, F2, F4 |
| transaction | EFX | Common Stock | Sale | $869,590 | -3,757 | -2.2% | $231.46 | 166,758 | 27 Oct 2025 | Direct | F1, F2, F5 |
| transaction | EFX | Common Stock | Sale | $935,549 | -4,015 | -2.4% | $233.01 | 162,743 | 27 Oct 2025 | Direct | F1, F2, F6 |
| transaction | EFX | Common Stock | Sale | $1,427,255 | -6,227 | -3.8% | $229.20 | 156,516 | 27 Oct 2025 | Direct | F1, F2, F7 |
| transaction | EFX | Common Stock | Sale | $1,528,192 | -6,639 | -4.2% | $230.18 | 149,877 | 27 Oct 2025 | Direct | F1, F2, F8 |
| transaction | EFX | Common Stock | Sale | $1,612,086 | -6,943 | -4.6% | $232.19 | 142,934 | 27 Oct 2025 | Direct | F1, F2, F9 |
| transaction | EFX | Common Stock | Sale | $8,656 | -37 | -0.09% | $233.95 | 43,394 | 27 Oct 2025 | 2-yr Jun 2025 GRAT | F1, F10 |
| transaction | EFX | Common Stock | Sale | $17,855 | -76 | -0.18% | $234.93 | 43,318 | 27 Oct 2025 | 2-yr Jun 2025 GRAT | F1 |
| transaction | EFX | Common Stock | Sale | $652,979 | -2,801 | -6.5% | $233.12 | 40,517 | 27 Oct 2025 | 2-yr Jun 2025 GRAT | F1, F11 |
| transaction | EFX | Common Stock | Sale | $771,439 | -3,331 | -8.2% | $231.59 | 37,186 | 27 Oct 2025 | 2-yr Jun 2025 GRAT | F1, F12 |
| transaction | EFX | Common Stock | Sale | $915,337 | -3,995 | -11% | $229.12 | 33,191 | 27 Oct 2025 | 2-yr Jun 2025 GRAT | F1, F13 |
| transaction | EFX | Common Stock | Sale | $1,224,994 | -5,274 | -16% | $232.27 | 27,917 | 27 Oct 2025 | 2-yr Jun 2025 GRAT | F1, F14 |
| transaction | EFX | Common Stock | Sale | $1,351,500 | -5,872 | -21% | $230.16 | 22,045 | 27 Oct 2025 | 2-yr Jun 2025 GRAT | F1, F15 |
| holding | EFX | Common Stock | 10,500 | 27 Oct 2025 | 2-yr 2025 GRAT | ||||||
| holding | EFX | Common Stock | 9,525 | 27 Oct 2025 | 2-yr Feb 2024 GRAT | ||||||
| holding | EFX | Common Stock | 11,380 | 27 Oct 2025 | 2-yr Jul 2024 GRAT | ||||||
| holding | EFX | Common Stock | 12,333 | 27 Oct 2025 | 2-yr May 2025 GRAT | ||||||
| holding | EFX | Common Stock | 16,287 | 27 Oct 2025 | 3-yr Jul 2024 GRAT |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EFX | Stock Option/Right to Buy | Options Exercise | $0 | -27,959 | -100% | $0.000000 | 0 | 27 Oct 2025 | Common Stock | 27,959 | $191.44 | Direct | F16 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024. |
| F2 | Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. |
| F3 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $233.795 to $234.215, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F4 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $234.93 to $235.43, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F5 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $230.74 to $231.734, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F6 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $232.74 to $233.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F7 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $228.73 to $229.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F8 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $229.74 to $230.72, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F9 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $231.735 to $232.71, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F10 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $233.88 to $234.215, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F11 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $232.85 to $233.80, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F12 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $230.83 to $231.82, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F13 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $228.73 to $229.685, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F14 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $231.845 to $232.81, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F15 | The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $229.7507 to $230.7266, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. |
| F16 | The option vested in three equal annual increments beginning 2/21/2021. |